PharmEng Nordic ApS: Financial statements 2023
CVR: 43181033
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PharmEng Nordic ApS (CVR 43181033) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 583,327 and a net result of DKK -941,012. Equity in the 2023 report amounted to DKK -1,177,365. The company had 2 employees in the financial year.
- Gross Profit
- DKK 583,327
- Profit/Loss
- DKK -941,012
- Equity
- DKK -1,177,365
- Total Assets
- DKK 1,243,392
- Employees
- 2
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PharmEng Nordic ApS has published its interim report for the period April 1, 2022 to December 31, 2022.
About PharmEng Nordic ApS
PharmEng Nordic ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2022. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Mathieu Charles Louis Roger, Olivier Claude Gillot and Olivier Tambuzzo. The company is owned by Efor Group SAS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 295,768 and a net result of DKK -1,108,665 compared with DKK -876,098 the year before. Equity in the 2025 report amounted to DKK -3,162,128.